Congress
$1,001–$15,000
Traded Sep 3 · disclosed 39 days later
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 15, 2026 · Filed Sep 16, 2026
A Globus Medical director sold $2.24M of Globus Medical shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$2,237,502
Shares × reported transaction price
40 days after results of Aug 6, 2026, 51 days before results of Nov 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $74.69 on Sep 15, 2026, 36% above its 52-week low and 23% below its high, after an 8% drop over the previous 30 trading days
52-week range $55.10 (Sep 25, 2025) to $96.82 (Apr 20, 2026), 47% of the way up, from 251 adjusted closes. 30 trading days earlier: $81.46 on Aug 3, 2026. Describes the past only, not a forecast
RSI 35, 13% under its 200-day average, 7% under its 50-day average, 23% below the 52-week high, 20-day volatility 30% a year, against the S&P 500: −11 points over 1 month, −4 points over 3 months, −26 points over 6 months
From the adjusted closes up to Sep 15, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
James R Tobin's largest sale of GMED in their filings since 2019. James R Tobin's first sale of GMED since Mar 2022
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.1% | +0.6% | −0.5% |
| 30 days | +2.0% | +0.5% | +1.5% |
Past results only. Not a forecast.
Congress
Traded Sep 3 · disclosed 39 days later
Insider filing
Traded Sep 15 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Sep 15 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.